Verastem to Present at 2015 JMP Securities Life Sciences Conference

BOSTON--()--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the 2015 JMP Securities Life Sciences Conference on Tuesday, June 23 at 9:00 a.m. ET at The St. Regis New York in New York City.

A live webcast of the presentation will be available on the company's website at http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-calendar. An archived presentation will be available for 90 days.

About Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK and PI3K/mTOR. For more information, please visit www.verastem.com.

Contacts

Verastem, Inc.
Brian Sullivan, 781-292-4214
bsullivan@verastem.com

Contacts

Verastem, Inc.
Brian Sullivan, 781-292-4214
bsullivan@verastem.com